Vaccine

Moderna trials in children show ‘strong immune response’

October 26, 2021 7:49 AM

Published October 26, 2021 7:29 AM

(KYMA, KECY) - Moderna is applauding the trial results of its COVID-19 vaccine for school-age children.

The pharmaceutical company says its trial showed smaller doses generated a "strong immune response" in children ages six to 11.

More than 4,700 children participated.

They were given two 50 microgram doses of Moderna’s vaccine, 28 days apart.

Smaller than the 100 microgram dose given to adults.

Moderna says the kids' antibody response kicked in one month after the second dose.

The most common side effects included fatigue, headache and fever.

Article Topic Follows: Vaccine

Jump to comments ↓

April Hettinger

April was born and raised in San Diego where she loved the beach town and her two dogs, Lexi and Malibu. She decided to trade the beach for the snow and advanced her education at Northern Arizona University in Flagstaff.

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.